The Fast Money traders take a look at today's biggest market movers.» Read More
Regular blog readers are well aware of my relentless pursuit of big CEO interviews. So, I wanted to give the backstory to a surprising CEO cancellation of a previously scheduled and confirmed interview today by Bristol-Myers Squibb. A few weeks ago, my producer Ruth and I got tentative confirmation from a Bristol spokesman that the relatively new CEO Jim Cornelius would finally do his first TV interview since taking over the company last year.
China and online advertisers will be the saviors of the advertising industry, according to Sir Martin Sorrell, CEO of advertising giant WPP.
I don't know how they all got clustered together--maybe so many of the major pharmaceutical companies meet with Wall Street in early December so everyone can then take off on long vacations--but my hands are full with three big pharma events in as many days. Yesterday, Merck put out guidance.
C-suite confidence is at its lowest level since May of 2003, according to a new survey by Chief Executive Magazine.
Merrill Lynch's new Chief Executive John Thain has received about $2.6 million in restricted stock and nearly 43,000 options to replace shares he forfeited by leaving NYSE Euronext, according to U.S. regulatory filings.
Josef Ackermann, Chief Executive of Deutsche Bank, has turned down an approach from Citigroup about taking the CEO job vacated last month by Charles Prince, the Financial Times reported.
Shares of Dow component Merck are trading lower in the very early going this morning after the country's second-biggest drug company didn't blow people away with its 2008 financial guidance. Merck puts out its new forecast a week ahead of its annual analyst meeting, so it can focus more on its drug development pipeline at the event.
One viewer thinks so. But Cramer won't apologize for being outraged. Also, clearing up the difference between portfolio cash and savings account cash.Investing can be confusing. Luckily, Cramer has mapped out some road rules for all you Home Gamers trying to navigate the jungle that is Wall Street. Think of it as "Mad Money 101" –- some fundamental advice to keep in mind as you play the market. Whether you're a first time investor or a seasoned financier, it's always good to remember the basics.
Merrill Lynch named NYSE Euronext Chief Financial Officer Nelson Chai as the investment bank's new CFO, replacing Jeffrey Edwards, effective Dec. 10.
You heard me rant here on this blog about Lululemon failing to answer questions about its Vitasea line and whether or not it truly contains seaweed. They were late in issuing a press release and defending their products but finally, in his first public comments, CEO Bob Meers joined us live on CNBC to defend the athletic wear company.
Liquidity is up. Overhead is down. That's the good news at Countrywide Financial, according to Chairman and Chief Executive Angelo Mozilo. But in an exclusive interview with CNBC, Mozilo declined to say that the corner has been turned in the housing and credit markets.
Marsh & McLennan said Monday that Daniel Glaser will become chairman and chief executive of Marsh Inc, the insurance brokerage's main operating subsidiary, effective Dec. 10.
Motorola, which has been fending off criticism from shareholder Carl Icahn, has named Greg Brown as its chief executive, replacing Ed Zander, who will remain chairman until the company's annual meeting in May.
Senator Herb Kohl (D-Wisconsin), the Chairman of the Senate's Special Committee on Aging, has made public a copy of a letter he recently sent to Genentech's President of Product Development, Dr. Susan Desmond-Hellmann--a frequent guest on CNBC--regarding the company's new policy on the use of the eye drug Lucentis.
Who'd have thunk it. Russia has become one of the hottest and fastest growing auto markets in the world. Now Chrysler wants a piece of the action and it may wind teaming up with a Russian automaker GAZ. Today in Michigan Chrysler executives and Michigan's governor are reportedly set to meet the president of GAZ to discuss the Russian automaker investing in the U.S.
Regarding my post from yesterday about Lilly CEO Sidney Taurel, a spokesman left me a voicemail this morning to say it has no intention of backing out of the interview next week. I've got a tentative commitment from Bristol-Myers Squibb to interview its new CEO Jim Cornelius for the first time at that company's analyst meeting next week.
Apple CEO Steve Jobs, the man behind the popular iPod, is the world's most powerful businessman, according to Fortune Magazine's list of the 25 most influential executives.
If you arrive for work at CNBC headquarters early enough you can pick up a copy of "The Wall Street Journal" at the lobby desk when you walk in. Today, I grabbed mine and set it down on my desk while I logged onto my computer and cleaned out my inbox.
Executive search firm CT Partners took its annual look at the hottest jobs in business and the characteristics of the executives who fill these positions. Executives with a track record of managing risk are in demand.
Late yesterday, a bullet crossed the Dow Jones newswire saying, "FDA Warns GlaxoSmithKline on Breast-Cancer Drug Promotion." Almost immediately, my producer and I got a call from the CNBC staffer who was manning what we call our "Alerts Desk" asking us if we'd seen the news and if we could provide any context.